Home / Companies / Central Admixture Pharmacy Services, Inc.

Central Admixture Pharmacy Services, Inc.

FDA Regulatory Profile

Central Admixture Pharmacy Services, Inc. appears in FDA public data with 346 recalls — including 39 Class I (most serious) —, 0 510(k) clearances, 24 FDA inspections, and 6 compliance actions on record. Its most recent recall (D-0618-2026, Class II) was initiated on June 2, 2026.

Summary

Total Recalls
346 (39 Class I)
510(k) Clearances
0
Inspections
24
Compliance Actions
6

Recent Recalls

NumberClassProductDate
D-0618-2026Class IITotal Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856June 2, 2026
D-0272-2025Class IPHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central AdmiFebruary 20, 2025
D-0021-2024Class IIfentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy ServSeptember 21, 2023
D-0029-2024Class IIHYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central AdmSeptember 21, 2023
D-0031-2024Class IIHYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central AdmixSeptember 21, 2023
D-0004-2024Class IIlidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite September 21, 2023
D-0022-2024Class IIfentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 DSeptember 21, 2023
D-0009-2024Class IIfentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central AdmixtureSeptember 21, 2023
D-0013-2024Class IIfentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central AdmixtSeptember 21, 2023
D-0016-2024Class IIfentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fSeptember 21, 2023
D-0008-2024Class IIrocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc.September 21, 2023
D-0028-2024Class IIHYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central AdmSeptember 21, 2023
D-0007-2024Class IIPHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, CentraSeptember 21, 2023
D-0032-2024Class IIHYDROmorphone in dextrose 5%, 0.5 mg/5 mL, (0.1 mg/mL), 5 mL Syringe, Rx only, Central Admixture PhaSeptember 21, 2023
D-0014-2024Class IIfentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central AdmixtSeptember 21, 2023
D-0018-2024Class IImidazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture PharmacySeptember 21, 2023
D-0020-2024Class IIfentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook RSeptember 21, 2023
D-0006-2024Class IIPHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc.September 21, 2023
D-0027-2024Class IIHYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, CentraSeptember 21, 2023
D-0026-2024Class IIsuccinylcholine, 200 mg/10 mL, (20 mg/mL), 10 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, SSeptember 21, 2023

FDA data resources